SE9601556D0 - New pharmaceutical formulation of a thrombin inhibitor for parenteral use - Google Patents

New pharmaceutical formulation of a thrombin inhibitor for parenteral use

Info

Publication number
SE9601556D0
SE9601556D0 SE9601556A SE9601556A SE9601556D0 SE 9601556 D0 SE9601556 D0 SE 9601556D0 SE 9601556 A SE9601556 A SE 9601556A SE 9601556 A SE9601556 A SE 9601556A SE 9601556 D0 SE9601556 D0 SE 9601556D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical formulation
parenteral use
thrombin inhibitor
new pharmaceutical
inhibitor
Prior art date
Application number
SE9601556A
Other languages
Swedish (sv)
Inventor
Anna Lundgren
Ulla Stjernfelt
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9601556A priority Critical patent/SE9601556D0/en
Publication of SE9601556D0 publication Critical patent/SE9601556D0/en
Priority to ZA9703062A priority patent/ZA973062B/en
Priority to ARP970101517A priority patent/AR006664A1/en
Priority to IDP971318A priority patent/ID17334A/en
Priority to AU27195/97A priority patent/AU2719597A/en
Priority to PCT/SE1997/000676 priority patent/WO1997039770A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Abstract

A pharmaceutical formulation of a trombin inhibitor for parenteral use having an extended release effect.
SE9601556A 1996-04-24 1996-04-24 New pharmaceutical formulation of a thrombin inhibitor for parenteral use SE9601556D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE9601556A SE9601556D0 (en) 1996-04-24 1996-04-24 New pharmaceutical formulation of a thrombin inhibitor for parenteral use
ZA9703062A ZA973062B (en) 1996-04-24 1997-04-10 New pharmaceutical formulation of a thrombin inhibitor for parenteral use.
ARP970101517A AR006664A1 (en) 1996-04-24 1997-04-15 EXTENDED RELEASE FORMULATION OF A WATER-SOLUBLE THROMBINE INHIBITOR FOR PARENTERAL ADMINISTRATION, PROCESS FOR ITS PREPARATION, METHOD FOR ARTERIAL AND / OR POISONOUS THROMBOEMBOLISM AND USE OF A THROMBIN INHIBITOR
IDP971318A ID17334A (en) 1996-04-24 1997-04-21 LATEST PHARMACY FORMULATION OF THE LATEST TROMBIN INHIBITORS USED PARENTERALLY
AU27195/97A AU2719597A (en) 1996-04-24 1997-04-22 New pharmaceutical formulation of a thrombin inhibitor for parenteral use
PCT/SE1997/000676 WO1997039770A1 (en) 1996-04-24 1997-04-22 New pharmaceutical formulation of a thrombin inhibitor for parenteral use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601556A SE9601556D0 (en) 1996-04-24 1996-04-24 New pharmaceutical formulation of a thrombin inhibitor for parenteral use

Publications (1)

Publication Number Publication Date
SE9601556D0 true SE9601556D0 (en) 1996-04-24

Family

ID=20402321

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601556A SE9601556D0 (en) 1996-04-24 1996-04-24 New pharmaceutical formulation of a thrombin inhibitor for parenteral use

Country Status (6)

Country Link
AR (1) AR006664A1 (en)
AU (1) AU2719597A (en)
ID (1) ID17334A (en)
SE (1) SE9601556D0 (en)
WO (1) WO1997039770A1 (en)
ZA (1) ZA973062B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802938D0 (en) * 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
SE9802973D0 (en) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
SE9900070D0 (en) 1999-01-13 1999-01-13 Astra Ab New use
FR2793418B1 (en) * 1999-05-11 2001-07-27 Synthelabo GALENIC FORMULATIONS OF ANTITHROMBOTIC AGENTS FOR SUBCUTANEOUS ADMINISTRATION
SE9902202D0 (en) 1999-06-10 1999-06-10 Astra Ab Production of aggregates
SE0001803D0 (en) 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
GB0014134D0 (en) * 2000-06-10 2000-08-02 Astrazeneca Ab Combination therapy
GB0014136D0 (en) * 2000-06-10 2000-08-02 Astrazeneca Ab Combination therapy
PE20020300A1 (en) 2000-08-22 2002-05-10 Pharmacia Corp COMPOSITION OF SOLUTION OF AN ANTIBIOTIC DRUG BASED ON OXAZOLIDINONE WITH IMPROVEMENT OF DRUG LOAD
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
AR035216A1 (en) 2000-12-01 2004-05-05 Astrazeneca Ab MANDELIC ACID DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE DERIVATIVES, USE OF THESE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES, TREATMENT METHODS, PROCESSES FOR THE PREPARATION OF THESE DERIVATIVES, AND INTERMEDIARY COMPOUNDS
SE0101762D0 (en) * 2001-05-18 2001-05-18 Astrazeneca Ab New use
SE0201661D0 (en) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201658D0 (en) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
SE0201659D0 (en) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
JP4744149B2 (en) 2002-12-03 2011-08-10 ファーマサイクリックス インコーポレイテッド 2- (2-Hydroxybiphenyl-3-yl) -1H-benzimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
TW200827336A (en) 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20150079136A1 (en) * 2012-04-10 2015-03-19 Rubicon Research Private Limited Controlled release pharmaceutical formulations of direct thrombin inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (en) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse PHARMACEUTICAL PREPARATIONS OF SUBSTANCES MEDICAL OR UNSTABLE IN WATER AND METHOD FOR THE PRODUCTION THEREOF
DK93993D0 (en) * 1993-08-17 1993-08-17 Finn Molke Borgbjerg USE OF 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN FOR THE PREPARATION OF A SYSTEMIC ANALGETIC OPIOID PREPARATION

Also Published As

Publication number Publication date
AR006664A1 (en) 1999-09-08
ZA973062B (en) 1997-10-24
WO1997039770A1 (en) 1997-10-30
AU2719597A (en) 1997-11-12
ID17334A (en) 1997-12-18

Similar Documents

Publication Publication Date Title
SE9601556D0 (en) New pharmaceutical formulation of a thrombin inhibitor for parenteral use
ID19198A (en) HETEROSICLIC METALOPROTEASE INHIBITORS
DK0869966T3 (en) Prodrugs for thrombin inhibitors
ID18416A (en) DIHETEROSICLIC METALOPROTEASE INHIBITORS
ID18141A (en) 1,3-DIHETEROSICLIC METALOPROTEASE INHIBITORS
NO985874D0 (en) Certain phosphinyl derivatives useful as naaladase inhibitors
FI973282A (en) Thrombin inhibitors
NO20006717D0 (en) protease inhibitors
NO973764D0 (en) Novel dipeptidamidines as thrombin inhibitors
NO990548L (en) Inhibitors of cysteine protease
ATE239755T1 (en) THROMBIN INHIBITORS
ATE234091T1 (en) THROMBIN INHIBITORS
DE59711714D1 (en) thrombin inhibitors
EE9800044A (en) Prolyl endopeptidase inhibitors
DE69625230T2 (en) thrombin inhibitors
NO983283D0 (en) Hydrocamic acid-based collagenase inhibitors
ATE282629T1 (en) THROMBIN INHIBITORS
NO20000094D0 (en) 6-Azaur source derivatives as IL-5 inhibitors
ATE227571T1 (en) THROMBIN INHIBITORS
ID19929A (en) NAALADASE INHIBITORS
ID17400A (en) NAALADASE INHIBITORS
LV5826A4 (en) Tienamycin inactivated renal peptidase inhibitor